| Melissa Burnett, MS, CCC-SLP | |
|
915 Calus Holw, Boaz, KY 42027-9453 | |
| (270) 748-6727 | |
| Not Available |
| Full Name | Melissa Burnett |
|---|---|
| Gender | Female |
| Speciality | Speech-language Pathologist |
| Location | 915 Calus Holw, Boaz, Kentucky |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366809899 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 235Z00000X | Speech-language Pathologist | 2757 (Kentucky) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Melissa Burnett, MS, CCC-SLP 915 Calus Holw, Boaz, KY 42027-9453 Ph: (270) 748-6727 | Melissa Burnett, MS, CCC-SLP 915 Calus Holw, Boaz, KY 42027-9453 Ph: (270) 748-6727 |
News Archive
Echo Therapeutics, Inc., a medical device company focused on non-invasive continuous glucose monitoring (CGM) and associated technologies, today announced that, after numerous consultations with the Chinese government, its strategic partner, Medical Technologies Innovation Asia, Ltd., believes that Echo's locally produced needle-free CGM products will be designated as a Class 2 medical device.
UT Southwestern Medical Center maternal-fetal specialists have confirmed a potential new protocol to protect pregnant women who are at risk for hepatitis B, a health problem that affects 2 billion people worldwide.
TVG is pleased to welcome leading biotech and pharma executives at the 18th Annual BioPartnering Europe, held in London, UK. To open the conference, Dr. Anders Ekblom, Executive Vice President, Global Medicines Development at AstraZeneca, spoke about a commitment to innovation and AstraZeneca's unique approach to collaborations.
Quantel Medical today announced FDA 510(k) clearance for its Optimis Fusion integrated laser platform. The Optimis Fusion system combines advanced selective laser trabeculoplasty (SLT) photoregeneration therapy and traditional YAG photodisruption treatments to offer ophthalmologists a versatile armamentarium for treating both cataract and glaucoma in an efficient combination platform.
Transplant researchers at the University of Pittsburgh's Thomas E. Starzl Transplantation Institute have dramatically improved intestinal transplant graft survival, and reduced rejection and infection rates by successfully using a novel immunosuppression minimization protocol, thus improving patients' overall quality of life and avoiding the use of several anti-rejection drugs, which can cause serious infections and major complications.
› Verified 9 days ago
Angie Lynn Whitis, SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 784 Whitis Rd, Boaz, KY 42027 Phone: 270-658-3727 | |
Mrs. Marley K Snow, MS, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2055 Bryan Rd, Boaz, KY 42027 Phone: 270-564-6280 |